Ratings
0
Nobody has rated this yet. Be the first!
Works
6
Metastatic progression with resistance to aromatase inhibitors is driven by the steroid receptor coactivator SRC-1.
AIB1:ERα transcriptional activity is selectively enhanced in aromatase inhibitor-resistant breast cancer cells
Cyclooxygenase-2 predicts adverse effects of tamoxifen: a possible mechanism of role for nuclear HER2 in breast cancer patients
Coassociation of estrogen receptor and p160 proteins predicts resistance to endocrine treatment; SRC-1 is an independent predictor of breast cancer recurrence
Epigenetic reprogramming of HOXC10 in endocrine-resistant breast cancer
Identification and characterization of nucleolin as a COUP-TFII coactivator of retinoic acid receptor β transcription in breast cancer cells
